Acta NaturaeActa NaturaeActa Naturae2075-8251Acta Naturae Ltd1942610.32607/actanaturae.19426Research ArticlesЭкспериментальные статьиResearch ArticleMembrane Partitioning of TEMPO Discriminates Human Lung Cancer from Neighboring Normal CellsGasymovO. K.GasymovO. К.
Azerbaijan
oktaygasimov@gmail.comBakhishovaM. J.
Azerbaijan
matanat.baxishova93@gmail.comAslanovR. B.
Azerbaijan
rab_qaya@mail.ruMelikovaL. A.
Azerbaijan
Lmelikova20027@gmail.comAliyevJ. A.
Azerbaijan
oncology.az@mail.comInstitute of Biophysics, Ministry of Science and Education Republic of AzerbaijanNational Center of Oncology, Azerbaijan Republic Ministry of HealthNational Center of Oncology, Azerbaijan Republic Ministry of Health181220231541111200505202312102023Copyright ©; 2024, Gasymov O.K., Bakhishova M.J., Aslanov R.B., Melikova L.A., Aliyev J.A.Copyright ©; 2024, Касумов O.К., Бахишова М.Д., Асланов Р.Б., Меликова Л.A., Алиев Д.А.2024Gasymov O.K., Bakhishova M.J., Aslanov R.B., Melikova L.A., Aliyev J.A.Касумов O.К., Бахишова М.Д., Асланов Р.Б., Меликова Л.A., Алиев Д.А.https://creativecommons.org/licenses/by/4.0https://actanaturae.ru/2075-8251/article/view/19426

The plasma membranes of normal and cancer cells of the lung, breast, and colon tissues show considerably different lipid compositions that greatly influence their physicochemical properties. Partitioning of the spin probe 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) into the membranes of human lung normal and carcinoma cells was assessed by EPR spectroscopy to estimate the impact of the lipid compositions. The goal was to reveal potential strategies for cancer therapy attributable to the membrane properties. The study was conducted at pH values of 7.3 and 6.2, relevant to the microenvironments of normal and cancer cells, respectively. The TEMPO partitioning was examined in the temperature interval of 283–317K to reveal the efficacy of local hyperthermia used in chemotherapy. Results indicate that the TEMPO partitioning coefficient for the membranes of human lung carcinoma cells is significantly higher compared with that of neighboring normal cells. Increased partition coefficients were observed at relatively higher temperatures in both normal and cancer cells. However, compared to the normal cells, the cancer cells demonstrated higher partition coefficients in the studied temperature range. The data obtained with C12SL (spin-labeled analog of lauric acid) indicate that increased membrane dynamics of the cancer cells is a possible mechanism for enhanced partitioning of TEMPO. Free energy values for partitioning estimated for pH values of 6.2 and 7.3 show that TEMPO partitioning requires 30% less energy in the cancer cells at pH 7.3. TEMPO and its derivatives have previously been considered as theranostic agents in cancer research. Data suggest that TEMPO derivatives could be used to test if complementary alkalization therapy is effective for cancer patients receiving standard chemotherapy with local hyperthermia.

electron paramagnetic resonanceTEMPO partitioninglung carcinomacell membrane lipid compositioncell membrane sensitivityAzerbaijan Science FoundationAzerbaijan Science FoundationEİF-MQM-ETS-2020-1(35)-08/07/3-M-07Meacham C.E., Morrison S.J. // Nature. 2013. V. 501. № 7467. P. 328–337.Singh A.K., Arya R.K., Maheshwari S., Singh A., Meena S., Pandey P., Dormond O., Datta D. // Int. J. Cancer. 2015. V. 136. № 9. P. 1991–2000.Hanahan D., Weinberg R.A. // Cell. 2000. V. 100. № 1. P. 57–70.Rakoff-Nahoum S. // Yale J. Biol. Med. 2006. V. 79. № 3–4. P. 123–130.Casares D., Escribá P.V., Rosselló C.A. // Int. J. Mol. Sci. 2019. V. 20. № 9. P. 2167.Lorent J.H., Levental K.R., Ganesan L., Rivera-Longsworth G., Sezgin E., Doktorova M., Lyman E., Levental I. // Nat. Chem. Biol. 2020. V. 16. № 6. P. 644–652.Stieger B., Steiger J., Locher K.P. // Biochim. Biophys. Acta - Mol. Basis Dis. 2021. V. 1867. № 5. P. 166079. https://doi.org/10.1016/j.bbadis.2021.166079.Zulueta Díaz Y.L.M., Arnspang E.C. // Membranes. 2021. V. 11. № 11. P. 828.van Deventer S., Arp A.B., van Spriel A.B. // Trends Cell Biol. 2021. V. 31. № 2. P. 119–129.Raghunathan K., Kenworthy A.K. // Biochim. Biophys. Acta Biomembr. 2018. V. 1860. № 10. P. 2018–2031.Sackmann E., Tanaka M. // Biophys. Rev. 2021. V. 13. № 1. P. 123–138.Hristova K., Selsted M.E., White S.H. // J. Biol. Chem. 1997. V. 272. № 39. P. 24224–24233.Zalba S., ten Hagen T.L.M. // Cancer Treat. Rev. 2017. V. 52. P. 48–57.Szlasa W., Zendran I., Zalesińska A., Tarek M., Kulbacka J. // J. Bioenerg. Biomembr. 2020. V. 52. № 5. P. 321–342.Karnovsky M.J., Kleinfeld A.M., Hoover R.L., Klausner R.D. // J. Cell Biol. 1982. V. 94. № 1. P. 1–6.Owen D.M., Gaus K. // Front. Plant Sci. 2013. V. 4. https://doi.org/10.3389/fpls.2013.00503.Ursell T.S., Klug W.S., Phillips R. // Proc. Natl. Acad. Sci. USA. 2009. V. 106. № 32. P. 13301–13306.Feigenson G.W. // Biochim. Biophys. Acta Biomembr. 2009. V. 1788. № 1. P. 47–52.Preta G. // Front. Cell Dev. Biol. 2020. V. 8. P. 1–10.Jeon J.H., Kim S.K., Kim H.J., Chang J., Ahn C.M., Chang Y.S. // Lung Cancer. 2010. V. 69. № 2. P. 165–171. http://dx.doi.org/10.1016/j.lungcan.2009.10.014.Svensson R.U., Shaw R.J. // Cold Spring Harb. Symp. Quant. Biol. 2016. V. 81. № 1. P. 93–103.Munir R., Lisec J., Swinnen J.V., Zaidi N. // Br. J. Cancer. 2019. V. 120. № 12. P. 1090–1098. http://dx.doi.org/10.1038/s41416-019-0451-4.Swinnen J.V., Brusselmans K., Verhoeven G. // Curr. Opin. Clin. Nutr. Metab. Care. 2006. V. 9. № 4. P. 358–365.Hess D., Chisholm J.W., Igal R.A. // PLoS One. 2010. V. 5. № 6. https://doi.org/10.1371/journal.pone.0011394.Du A., Wang Z., Huang T., Xue S., Jiang C., Qiu G., Yuan K. // MedComm – Oncol. 2023. V. 2. № 1. P. 1–22.Gasymov O., Bakhishova M., Gasanova R., Aslanov R., Melikova L., Aliyev J. // Russ. J. Biol. Phys. Chemisrty. 2022. V. 7. № 2. P. 261–267.Bakhisova M., Aslanov R.B., Gasanova R.B., Melikova L., Aliyev J.A., Gasymov O.K. // Trans. ANAS, Phys. Astron. 2022. V. 52. № 5. P. 56–63.Guisasola E., Asín L., Beola L., De La Fuente J.M., Baeza A., Vallet-Regí M. // ACS Appl. Mater. Interfaces. 2018. V. 10. № 15. P. 12518–12525.Kang J.K., Kim J.C., Shin Y., Han S.M., Won W.R., Her J., Park J.Y., Oh K.T. // Arch. Pharm. Res. 2020. V. 43. № 1. P. 46–57.Anemone A., Consolino L., Arena F., Capozza M., Longo D.L. // Cancer Metastasis Rev. 2019. V. 38. № 1–2. P. 25–49.Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B., Gillies R.J. // Cancer Res. 2006. V. 66. № 10. P. 5216–5223.Gillies R.J., Pilot C., Marunaka Y., Fais S. // Biochim. Biophys. Acta - Rev. Cancer. 2019. V. 1871. № 2. P. 273–280.Gasanova R.B., Melikova L.A., Gasymov O.K., Aliyev J.A. // Mod. Achiev. Azerbaijan Med. 2020. № 4. P. 112–117.Budil D.E., Sanghyuk L., Saxena S., Freed J.H. // J. Magn. Reson. - Ser. A. 1996. V. 120. № 2. P. 155–189.Keith A., Bulfield G., Snipes W. // Biophys. J. 1970. V. 10. № 7. P. 618–629.Wu S.H. wei, McConnell H.M. // Biochemistry. 1975. V. 14. № 4. P. 847–854.Griffith O.H., Dehlinger P.J., Van S.P. // J. Membr. Biol. 1974. V. 15. № 1. P. 159–192.Gillies R.J., Robey I., Gatenby R.A. // J. Nucl. Med. 2008. V. 49. № 6. P. 24–43. doi: 10.2967/jnumed.107.047258.Tennant D.A., Durán R.V., Gottlieb E. // Nat. Rev. Cancer. 2010. V. 10. № 4. P. 267–277.Webb B.A., Chimenti M., Jacobson M.P., Barber D.L. // Nat. Rev. Cancer. 2011. V. 11. № 9. P. 671–677.Ribeiro Md.L.C., Silva A.S., Bailey K.M., Kumar N.B., Seller T.A., et al. // J. Nutr. Food Sci. 2012. V. 1. № S2. P. 1–7.Soule B.P., Hyodo F., Matsumoto K.I., Simone N.L., Cook J.A., Krishna M.C., Mitchell J.B. // Antioxidants Redox Signal. 2007. V. 9. № 10. P. 1731–1743.Lewandowski M., Gwozdzinski K. // Int. J. Mol. Sci. 2017. V. 18. № 11. P. 2490.Suy S., Mitchell J.B., Samuni A., Mueller S., Kasid U. // Cancer. 2005. V. 103. № 6. P. 1302–1313.Park W.H. // Molecules. 2022. V. 27. № 21. P. 7341.Andreidesz K., Szabo A., Kovacs D., Koszegi B., Vantus V.B., Vamos E., Isbera M., Kalai T., Bognar Z., Kovacs K., et al. // Int. J. Mol. Sci. 2021. V. 22. № 16. P. 1406.Wang M., Li K., Zou Z., Li L., Zhu L., Wang Q., Gao W., Wang Y., Huang W., Liu R., et al. // Oncol. Lett. 2018. V. 16. № 4. P. 4847–4854.Widomska J., Raguz M., Dillon J., Gaillard E.R., Subczynski W.K. // Biochim. Biophys. Acta Biomembr. 2007. V. 1768. № 6. P. 1454–1465.Liu Y.Q., Ohkoshi E., Li L.H., Yang L., Lee K.H. // Bioorganic Med. Chem. Lett. 2012. V. 22. № 2. P. 920–923. http://dx.doi.org/10.1016/j.bmcl.2011.12.024.Guo X., Seo J.-E., Bryce S.M., Tan J.A., Wu Q., Dial S.L., Moore M.M., Mei N. // Toxicol. Sci. 2018. V. 163. № 1. P. 214–225.Gariboldi M.B., Lucchi S., Caserini C., Supino R., Oliva C., Monti E. // Free Radic. Biol. Med. 1998. V. 24. № 6. P. 913–923.Zhao X.-B., Wu D., Wang M.-J., Goto M., Morris-Natschke S.L., Liu Y.-Q., Wu X.-B., Song Z.-L., Zhu G.-X., Lee K.-H. // Bioorg. Med. Chem. 2014. V. 22. № 22. P. 6453–6458.Kroll C., Langner A., Borchert H.H. // Free Radic. Biol. Med. 1999. V. 26. № 7–8. P. 850–857.Kroll C., Borchert H.H. // Eur. J. Pharm. Sci. 1999. V. 8. № 1. P. 5–9.